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Ubiquitin signals and ubiquitin-binding domains are implicated in almost every cellular process, but
how is their functionality achieved in cells? We assess recent advances in monitoring the dynamics
and specificity of ubiquitin networks in vivo and discuss challenges ahead.Introduction
A small protein modifier, ubiquitin, is the
building block of a repertoire of molecular
signals spanning from single ubiquitin
to ubiquitin chains of different linkage
used for posttranslational modification of
dozens of cellular proteins (Hershko and
Ciechanover, 1998). The seven lysines
(K) of ubiquitin (K6, K11, K27, K29, K33,
K48, and K63) and the amino-terminal
methionine (M1) are connected to the
C-terminal glycine for chain assembly,
generating polymers (Ikeda and Dikic,
2008; Iwai and Tokunaga, 2009). Ubiquitin
signals are recognized and processed
by specialized ubiquitin-binding domains
(UBDs) that form transient, noncovalent
interactions either with ubiquitin moieties
or with the linkage region in their chains.
So far, roughly 200 intracellular proteins
have been recognized to contain one
or more UBDs (Dikic et al., 2009). Ubiqui-
tin-UBD interactions regulate almost
every aspect of cellular physiology,
including protein degradation, receptor
trafficking, DNA repair, cell-cycle pro-
gression, gene transcription, autophagy,
and apoptosis (recently reviewed in
Deshaies and Joazeiro, 2009; Kirkin
et al., 2009; Raiborg and Stenmark,
2009; Ulrich and Walden, 2010; Wickliffe
et al., 2009; Winget and Mayor, 2010).
Yet, very little is known about the nature
of ubiquitin signals and the dynamics
of their interpretation by UBDs in the
highly crowded molecular environment
of the cell. In particular, it remains unclear
how a relatively limited pool of signals
(ubiquitin chains and UBDs) with partially
overlapping biochemical properties can
orchestrate the localization and functionof thousands of proteins involved in very
different cellular processes. Here we
summarize the most recent advances in
understanding specificity determinants
in ubiquitin signaling and discuss future
challenges in the development of sensi-
tive and reliable methods for monitoring
spatial and temporal patterns of ubiquiti-
nation in vivo.
Diversity of Ubiquitin Signals
Despite its relatively rigid globular struc-
ture, ubiquitin is one of the most versatile
signaling molecules in the cell. Although
the surface of ubiquitin is mostly com-
posed of polar residues, it is through its
few hydrophobic patches that it interacts
with most UBDs (Dikic et al., 2009;Winget
and Mayor, 2010). Moreover, the pres-
ence of seven lysine residues and the
N-terminal methionine within ubiquitin
that can be fused to the C-terminal di-
glycine motif of another ubiquitin allows
the formation of polymeric chains en-
dowed with flexibility, as in the case of
K63-linked or M1-linked chains (often
referred to as linear) (Ikeda and Dikic,
2008; Iwai and Tokunaga, 2009). K48-
linked and K11-linked chains adopt
a more rigid conformation, in which ubiq-
uitin monomers are tightly packed against
each other. This creates unique modules
composed of aligned ubiquitin moieties
in which the hydrophobic patch contain-
ing isoleucine 44 is either embedded or
facing out toward the surface (Pickart
and Fushman, 2004; Bremm et al., 2010;
Matsumoto et al., 2010). Conversely,
K6-linked chains form an asymmetric
compact conformation distinct from any
other known type of ubiquitin chainCell 143, N(Virdee et al., 2010). The possibility of
heterotypic ubiquitin chains (that is, with
mixed linkages) has been shown in vitro,
but their presence and biological func-
tions in vivo remain to be confirmed. Alto-
gether, monoubiquitin and homotypic
polyubiquitin chains comprise no more
than ten signal types. However, the ability
to synthesize homotypic chains of various
lengths indicates that the repertoire of
ubiquitin signals in the cell may be larger
than expected.
Signals Decoders:
Ubiquitin-Binding Domains
Ubiquitin signals are read and processed
by UBDs that bind noncovalently to
mono- or polyubiquitin chains. To date,
five structural folds are known with
more than 20 UBDs identified overall
(Dikic et al., 2009). UBDs are commonly
a-helical structures, zinc fingers, pleck-
strin homology (PH) folds, or similar to
the ubiquitin-conjugating (Ubc) domain
present in E2 enzymes (Dikic et al.,
2009). In the majority of cases, isolated
UBDs preferentially bind tomonoubiquitin
via a conserved hydrophobic patch sur-
rounding isoleucine 44. The measured
affinity of isolated UBDs for monoubiqui-
tin typically falls in the micromolar range
(Dikic et al., 2009; Winget and Mayor,
2010). In certain cases, monoubiquitin-
UBD interactions have also been demon-
strated in the context of endogenous full-
size proteins. For example, UBDs present
in Y family polymerases performing DNA
translesion synthesis bind the monoubi-
quitinated sliding clamp PCNA (Bienko
et al., 2005), and monoubiquitinated
transmembrane receptors are recognizedovember 24, 2010 ª2010 Elsevier Inc. 677
by endocytic sorting proteins containing
diverse UBDs (Hicke and Dunn, 2003).
The affinity of UBD-containing proteins
for their monoubiquitinated targets in the
cellular environment, however, may be
different from that inferred from in vitro
studies. In fact, the way ubiquitin signals
are decoded in cells may be influenced
by multiple factors, including the pres-
ence of tandem copies of one UBD in
the same protein, oligomerization, and
protein compartmentalization (reviewed
in Dikic et al., 2009; Winget and Mayor,
2010).
In addition to monoubiquitin, many
UBDs display either relative or absolute
selectivity for certain types of chains
(Ikeda and Dikic, 2008; Dikic et al., 2009;
Winget and Mayor, 2010). For instance,
the Pru (Plextrin receptor for ubiquitin)
domain in the proteasome receptor
Rpn13 preferentially interacts with K48-
linked diubiquitin (Husnjak et al., 2008),
and the NZF (Npl4 zinc finger) domain in
TAK1-binding protein 2 (TAB2) binds
specifically to K63-linked ubiquitin (Kula-
thu et al., 2009; Sato et al., 2009). In con-
trast, UBDs in NEMO and ABIN proteins
(UBAN) bind linear diubiquitin chains
with approximately 100-fold higher affinity
than K63 or K48 chains, and binding to
monoubiqutitin could not be detected
(Rahighi et al., 2009; Lo et al., 2009). The
selectivity of UBAN for linear chains has
been explained by the observation that
a NEMO dimer binds symmetrically to
linear diubiquitin, involving direct interac-
tions with residues exposed in the
glycine-methionine linkages (Rahighi
et al., 2009). In addition, the crystal struc-
tures of the NZF domain of TAB2 and
TAB3 in complex with K63-linked diubi-
quitin have shown a two-sided ubiquitin-
binding surface thanks to a flexible
K-linkage positioned away from the
interaction surface (Kulathu et al., 2009;
Sato et al., 2009). Linkage selectivity can
also result from multivalent interaction
between tandem UBD arrays in a given
protein and ubiquitin monomers or link-
ages in a polyubiquitin chain. Tandem
ubiquitin-interacting motifs (UIMs) in the
DNA double-strand break response pro-
tein Rap80 are positioned to cross two
K63-linked monomers, whereas Ataxin-3
UIMs display K48 avidity (Sims and
Cohen, 2009). The proteasome receptor
S5a has two UIMs separated by linker678 Cell 143, November 24, 2010 ª2010 Elseregions and shows a 10-fold higher
affinity for diubiquitin over monoubiquitin
(Zhang et al., 2009). These observations
suggest that the function of tandem UBD
arrays is to increase the affinity for a given
ubiquitinated substrate rather than simul-
taneously binding multiple substrates.
Specificity and Plasticity
of Ubiquitin Signaling
Historically, distinct ubiquitin signals have
been linked to specific cellular functions.
For example, K48-linked chains, also
known as ‘‘classical’’ ubiquitin chains,
were originally described as the signal
that targets substrates for proteasomal
degradation (Hershko and Ciechanover,
1998). Nonclassical linkage types, such
as K63-, K11-, or M1-linked chains are
instead associated with DNA repair
regulation, cell-cycle progression, innate
immunity, and inflammation (Ikeda and
Dikic, 2008; Iwai and Tokunaga, 2009;
Matsumoto et al., 2010; Wickliffe et al.,
2009). Recent reports, however, have
challenged the notion that distinct chain
types exclusively regulate specific pro-
cesses in the cell. For instance, nonclas-
sical ubiquitin signals, such as K11
chains generated by the anaphase-
promoting complex (APC/C), can also
target selected substrates for proteaso-
mal degradation (Jin et al., 2008). In yeast,
cyclin B1 is modified by a mix of K48-,
K63-, and K11-linked chains rather than
by K48 chains alone (Kirkpatrick et al.,
2006). This heterogeneous pool is suffi-
cient to bind to proteasomal ubiquitin
receptors and drive cyclin B1 degradation
(Kirkpatrick et al., 2006). Furthermore,
linear chains, initially discovered as acti-
vators of the NF-kB pathway (Tokunaga
et al., 2009), can also trigger proteasomal
degradation when fused to artificial sub-
strates (Zhao and Ulrich, 2010).
So, how is functional specificity of ubiq-
uitin signaling achieved in vivo? Even
though evidence indicates that specific
chain types control distinct molecular
processes, as clearly exemplified by
NF-kB signaling, we speculate that addi-
tional signals (monoubiquitin and chains
with different linkage and length) can
control the same molecular process with
different kinetics and spatial constraints.
It has also been speculated that unan-
chored ubiquitin chains can regulate
NF-kB activation (Xia et al., 2009).vier Inc.However, the importance of this regula-
tory mechanism in vivo remains to be
further investigated. Therefore, the de-
coding of ubiquitin signals might be per-
formed in vivo by different UBDs (not
necessarily endowed with absolute selec-
tivity toward monoubiquitin or a particular
chain type) embedded in key proteins
controlling a particular process. Although
this scenario could allow a certain degree
of plasticity in ubiquitin signaling, speci-
ficity might be determined by the localiza-
tion and assembly of UBD-containing
proteins and enzymes catalyzing ubiquiti-
nation reactions.
Catching Ubiquitin Signaling
in the Act
The huge discrepancy between our
current understanding of the ubiquitin
system from in vitro studies compared to
in vivo models stems from the fact that
ubiquitination and its recognition and
cleavage occur in milliseconds (Pierce
et al., 2009), therefore making it chal-
lenging to analyze these events in living
systems. The first attempts to study ubiq-
uitin signaling in vivo have used anti-
bodies against monoubiquitin, polyubi-
quitin chains, or, more recently, selective
linkages, including K11, K48, K63, and
linear chains (Matsumoto et al., 2010;
Newton et al., 2008; Wang et al., 2008;
Tokunaga et al., 2009) (Figure 1A). Raising
linkage-selective antibodies is not easy,
despite being urgently needed to provide
tools to discriminate between different
chain types in the cell. These antibodies
were produced either by synthesizing
peptides resembling specific linkage
bonds (Wang et al., 2008; Tokunaga
et al., 2009) or by using the phage-display
method (Matsumoto et al., 2010; Newton
et al., 2008). Although chain-selective
antibodies have been used to demon-
strate specific chain formation in several
biological settings (such as the NF-kB
pathway and cell-cycle progression), their
ability to monitor substrates with low
abundance and the dynamics of chain
(de)conjugation as well as their distribu-
tion in vivo are still very limited.
Monoclonal antibodies recognizing di-
glycine-modified lysines have been used
in combination with mass spectrometry
in efforts to increase the sensitivity of
immune-based techniques (Xu et al.,
2010) (Figure 1B). These antibodies enrich
Figure 1. Antibodies for Ubiquitin Signals
(A) Linkage-specific antibodies, such as a-lysine 11(K11)-, a-K48-, a-K63-
linked ubiquitin chains and a-linear ubiquitin chains, can be applied for the
detection of endogenous ubiquitination of a specific linkage type.
(B) After trypsin digestion of total cell extracts, immunoprecipitation of the
samples by a specific antibody against glycine-glycine-lysine peptides
(a-GGK Ab) can enrich fragments with ubiquitinated K residues from both
substrates and ubiquitin chains. Analysis by mass spectrometry enables the
identification of new target proteins as well as sites of ubiquitination.for the C-terminal di-glycine
motif of ubiquitin attached to
the acceptor lysine following
proteolysis of ubiquitinated
proteins by trypsin (Fig-
ure 1B). This method revealed
more than 200 ubiquitinated
proteins from human embry-
onic kidney 293 cells, the
majority of which were previ-
ously unknown targets (Xu
et al., 2010). This strategy
can be coupled to stable
isotope labeling with amino
acids in cell culture (SILAC)
to quantitatively explore pro-
tein ubiquitination in diverse
biological settings. However,
it needs to be noted that
this approach can neither
detect short-lived proteins
nor distinguish lysine modifi-
cation by NEDD8.
The AQUA (absolute quan-
tification) method developed
in the Gygi laboratory is
another promising approach
to measure the dynamics of
ubiquitin signaling in cells
(Kirkpatrick et al., 2005).
AQUA relies on the use of
stable isotope-labeled inter-
nal standard peptides that
mimic those produced during
tryptic digestion of ubiquiti-
nated proteins of interest.
In case of mono- or polyubi-
quitinated proteins, tryptic
digestion produces a seriesof unbranched and di-glycine-
branched peptides. Initial analysis of
such mixtures allows identification of
ubiquitination sites in the substrate and
the type of ubiquitin chain linkage (such
as monoubiquitination or K63- or K48-
ubiquitin chains). Based on this informa-
tion, substrate-, site-, and linkage-specific
reference peptides are synthesized and
used as quantitative internal standards,
allowing for precise quantification of
monoubiquitin and polyubiquitin chains
by targeted proteomics approaches such
as selective reaction monitoring. With
this methodology, the stoichiometry of
ubiquitin moieties on a protein of interest
can be determined (Figure 2A). Its
simplicity and sensitivity, coupled with
the current widespread availability oftandem mass spectrometers, makes
AQUA the tool of choice for quantitatively
measuring ubiquitin modifications directly
in cell lysates (Kirkpatrick et al., 2006).
What Is Known about Ubiquitin
Chain Length In Vivo?
The methods described above are pre-
dicted to provide quantitative information
on the repertoire of ubiquitin signals and
ubiquitinated proteins generated in dif-
ferent biological settings. However, these
methods cannot monitor the length of
ubiquitin chains in vivo. At present, all
our knowledge on their length in vivo
relies on nonquantitative analysis of
immunoblots. Several procedures have
been designed to cause ubiquitin chains
and polyubiquitinated substrates to accu-Cell 143, November 24mulate in the cell to facilitate
their detection, including the
use of inhibitors of the pro-
teasome and of deubiquiti-
nating enzymes (DUBs). This
has often led to the conclu-
sion that high-mobility ubiqui-
tin-positive smears observed
on immunoblots represent
the natural modification of
substrates by very long ubiq-
uitin chains. This, however,
can be misleading because
the combination of different
ubiquitin signals (monoubi-
quitin or ubiquitin chains) on
the same type of substrate
can also yield high-mobility
smears (Haglund et al.,
2003; Huang et al., 2006),
and inhibition of DUBs and
the proteasome may cause
an overrepresentation of
long ubiquitin chains that
might not naturally occur in
the cell.
The question of chain
length is important given that
chains with different topology
and length may regulate dif-
ferent cellular functions. For
instance, the length of K48-
linked tetraubiquitin chains
is optimized for interaction
with proteasomal receptors
(Pickart and Fushman, 2004),
as a ternary complex can
be formed between the ubiq-
uitin chains and proteasomalreceptors Rpn13 and S5a (Zhang et al.,
2009). Moreover, given that trimming
of ubiquitinated substrates occurs from
the distal end of the chains, it seems
that the length of K48-linked chains
dictates the duration of proteasomal
degradation (Lee et al., 2010).
Monoubiquitination can also drive pro-
teins to proteasomal degradation (Shabek
et al., 2009). These observations collec-
tively suggest that the ubiquitin chain
length required for proteasomal degrada-
tion is determined by the substrate’s
affinity for the proteasome and must be
just high enough to allow processivity of
the proteolytic process. This kind of
adjustment is most likely controlled by
a proteasome-associated complex,
which is equipped with both ubiquitin, 2010 ª2010 Elsevier Inc. 679
Figure 2. Quantification and Detection of Ubiquitin Chains In Vivo
(A) The workflow for the AQUA (absolute quantification) method of quantitative
mass spectrometry is depicted. First, a representative tryptic peptide is selected
based on initial proteomic sequencing experiments and then synthesized with
a stable isotope at one residue for identification. The tryptic peptide sequence
for lysine48 (K48)-linkedubiquitinchains is indicated (upperpanel).AQUApeptide
standards are added to the sample (cell lysates or immunocomplexes) prior to
trypsin digestion and targeted proteomic analysis is performed using selective
reaction monitoring. The amount of total protein and the extent of ubiquitination
at that particular site can be determined by comparing the precise amounts of
the unmodified and ubiquitinated versions of the peptide (lower panel).
(B) Schematic models of ubiquitin sensors are shown. By using different ubiq-
uitin-binding domains (UBDs), the sensor can be applied for specific linkage
type of ubiquitin chains (left), such as K48, K63, and linear chains. Tandem
UBDs may be used to determine the chain length (right). One UBD recognizes
1 unit of diubiquitin. The tag chosen depends on the experimental purposes.ligase (HUL5) and deubiquiti-
nating (UBP6) activities (Cro-
sas et al., 2006).
In the case of the NF-kB
pathway, distinct activation
steps involve K63, linear,
and K48 chains (Bianchi and
Meier, 2009), which are
further edited (in length and
topology) by ligases and
DUBs (Wertz et al., 2004;
Newton et al., 2008). An initial
mechanism proposed for NF-
kB activation implicated long
K63-linked chains in the
recruitment of TAK1 and IKK
kinases via their respective
adaptor proteins TAB2 and
NEMO (reviewed in Bianchi
and Meier, 2009). This model
has been challenged by the
demonstration that cells ex-
pressing ubiquitin lacking
K63 have intact NF-kB
signaling via tumor necrosis
factor-a receptors (Xu et al.,
2009). Interestingly, based
on available structures it
appears that chain-selective
UBDs in TAB2 and NEMO
interact with K63-linked or
linear diubiquitin chains,
respectively (Kulathu et al.,
2009; Rahighi et al., 2009;
Sato et al., 2009). Given that
no data are available on the
precise length of ubiquitin
chains in the NF-kB pathway,
it is tempting to speculate
that diubiquitin chains are
the fundamental units recog-
nized by selective UBDs.
However, UBDs also show
promiscuous binding with
lower affinities to other types
of chains. Examples include
the NZF domain of TAB2,
which also binds K48 chains
in solution (Kulathu et al.,
2009), and the UBAN domain
in NEMO, which interacts
with K63- and K48-linked
chains longer than diubiquitin
(Rahighi et al., 2009). We
speculate that diubiquitin
units in longer chains may
amplify signals that can be
recognized by nonselective680 Cell 143, November 24, 2010 ª2010 Elsevier Inc.UBDs. In such a scenario,
short ubiquitin chains added
to substrates will be preferen-
tially decoded by linkage-
selective UBDs, whereas
long chains may be promis-
cuously read by different
UBDs, possibly placing chain
length next to chain linkage
type in determining ubiquitin-
UBD selectivity.
Development of Sensors
Using Selective UBDs
In order to measure the
dynamics of ubiquitin chain
formation/disassembly and
their length in vivo, functional
ubiquitin sensors are needed
(Figure 2B). A recently engi-
neered sensor (TUBE, tan-
dem repeated ubiquitin enti-
ties) possesses four tandem
UBA domains of either HR23
or ubiquitin 1 (Hjerpe et al.,
2009). The ubiquitin-binding
capacity of TUBE is markedly
higher for ubiquitin tetramers
in comparison to monoubi-
quitin. In addition, the affinity
of the interaction of TUBE
with either K63- or K48-tet-
raubiquitin chains is much
greater than that of a single
UBA domain (Hjerpe et al.,
2009). An intriguing feature
of TUBE is its ability to pro-
tect ubiquitin chains from
cleavage by blocking acces-
sibility to DUBs.
The design principle of
TUBE could be easily adap-
ted to other UBDs: for ex-
ample, a K63 chain-specific
sensor could be created by
fusing multiple NZF domains
of TAB2 in tandem, a K48-
specific sensor by merging
multiple Pru domains of
Rpn13, and a linear-specific
sensor by arraying several
copies of the UBAN domain
of NEMO or ABINs. These
UBD-derived ubiquitin sen-
sors could be used to protect
and purify substrates deco-
rated with endogenous ubiq-
uitin chains. They could also
be used to determine the predominant
linkage type within these chains by
competition experiments and for
measuring the length of ubiquitin poly-
mers in their natural environment.
A further critical challenge will be to
evaluate chain-specific ubiquitin sensors
using advanced (high-throughput) single-
cell or -molecule microscopy. This might
permit the qualitative and quantitative
assessment of ubiquitin chain formation
and the interplay between different chain
types in vivo. Analyzing additional proper-
ties, such as the spatial and temporal
regulation of conjugation and deconjuga-
tion of ubiquitin chains as well as their
length in vivo, could enable a high-
resolution, systems-level analysis of the
‘‘ubiquitinome.’’Perspective
Even though we have attained a sophisti-
cated mechanistic understanding of the
ubiquitin system, it has beenmore difficult
to analyze the orchestration of its func-
tions in vivo. Within the cellular environ-
ment, ubiquitin signals must select the
correct binding partner at the right place
and time, ensuring accurate signaling.
To understand the specificity and
dynamics of the ubiquitin system in its
biological context, it is critical that highly
sensitive methods, such as mass spec-
trometry and advanced microscopy, are
deployed to measure key parameters,
such as the amount of different ubiquitin
signals, the kinetics of UBD-ubiquitin
recognition, and the type and length of
ubiquitin chains attached onto substrates
in vivo. By shedding light onto these prop-
erties, we will gain a deeper under-
standing of one of the most important
and widely used regulatory systems of
cell physiology.ACKNOWLEDGMENTS
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